Investor Presentaiton
Atos Medical is the global pioneer within Laryngectomy and has shaped
the market for the past +30 years
Key market and business highlights
Revenue by segment and geography
~50,000
New total laryngectomies per year
Laryngectomy
Tracheostomy
Other
Organic CAGR -8%
-85%
Global Laryngectomy market share
1.441
1.268
1.286
30
Countries with direct presence
1.175
▪72=
89
72
227
107
152
162
171
-50%
of revenues from Direct to consumer sales
~1,100
Employees globally
1.027
1.052
1.142
897
Atos product segments
Lary
Heat- and Moisture Exchanger (HMES)
Adhesives (Adh)
Voice Prostheses (VP)
Accessories
PROVOK
BROVCI
2018
2019
2020
20212
-80%
-20%
-75%
-10%
-15%
Tracheostomy & ENT
1)
53
2)
Pro-forma revenues and adjusted EBITDA calculated by Coloplast, including TRACOE medical GmbH and
Kapitex Healthcare LTD (together "Tracoe"). Atos closed the Tracoe transaction on October 1st 2021.
Includes impact from the Tracoe acquisition
Laryngectomy
Tracheostomy & Other
Europe
North America
ROW
ColoplastView entire presentation